Fuji Pharma Co., Ltd. (FRA:FUP)

Fuji Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	228	194	179	177	220	314
Market Cap Growth	-5.31%	8.06%	1.24%	-19.45%	-30.05%	-9.73%
Enterprise Value	371	358	342	324	287	322
Last Close Price	9.20	7.89	6.98	6.67	8.23	8.61
PE Ratio	12.59	5.04	8.25	9.32	11.68	18.67
PS Ratio	0.77	0.67	0.69	0.71	0.84	1.15
PB Ratio	0.85	0.68	0.69	0.70	0.87	0.97
P/TBV Ratio	1.14	0.94	0.92	0.99	0.94	1.05
P/FCF Ratio	-	22.54	-	-	12.89	11.29
P/OCF Ratio	-	7.46	14.78	-	4.74	6.75
EV/Sales Ratio	1.28	1.24	1.32	1.30	1.09	1.18
EV/EBITDA Ratio	-	7.56	7.85	7.04	6.79	7.68
EV/EBIT Ratio	12.71	14.72	14.01	12.15	11.06	12.71
EV/FCF Ratio	-	41.61	-	-	16.81	11.58
Debt / Equity Ratio	0.69	0.64	0.70	0.69	0.57	0.31
Debt / EBITDA Ratio	-	3.87	4.21	3.77	3.42	2.35
Debt / FCF Ratio	-	21.31	-	-	8.47	3.54
Asset Turnover	0.55	0.53	0.51	0.51	0.54	0.55
Inventory Turnover	1.36	1.51	1.39	1.50	1.70	1.77
Quick Ratio	0.76	0.66	0.63	0.68	1.10	2.16
Current Ratio	1.53	1.19	1.31	1.45	1.73	3.18
Return on Equity (ROE)	6.78%	14.17%	8.92%	7.87%	6.70%	5.26%
Return on Assets (ROA)	3.46%	2.77%	3.00%	3.38%	3.32%	3.20%
Return on Capital (ROIC)	4.17%	3.35%	3.70%	4.23%	4.04%	3.83%
Return on Capital Employed (ROCE)	8.20%	7.20%	6.90%	7.30%	7.60%	6.20%
Earnings Yield	7.94%	19.86%	12.12%	10.73%	8.56%	5.36%
FCF Yield	-	4.44%	-4.98%	-22.91%	7.76%	8.86%
Dividend Yield	2.99%	3.37%	3.35%	3.70%	2.73%	2.72%
Payout Ratio	-	15.82%	26.17%	27.04%	33.18%	43.36%
Buyback Yield / Dilution	-0.25%	-0.04%	-0.03%	9.58%	13.77%	-2.06%
Total Shareholder Return	2.74%	3.33%	3.32%	13.28%	16.50%	0.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.